Article contents
Melanoma-Associated Retinopathy Report of a Case and Review
Published online by Cambridge University Press: 02 December 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Letters to the Editor
- Information
- Copyright
- Copyright © The Canadian Journal of Neurological 2011
References
1.Milam, AH, Saari, JC, Jacobson, SG, Lubinski, WP, Feun, LG, Alexander, Kr. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34(1):91–100.Google ScholarPubMed
2.Chan, C, O’Day, J.Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Experiment Ophthalmol. 2001;29(4):235–8.CrossRefGoogle ScholarPubMed
3.Lu, Y, Jia, L, He, S, et al.Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol. 2009;127(12):1572–80.CrossRefGoogle ScholarPubMed
4.Ladewig, G, Reinhold, U, Thirkill, CE, Kerber, A, Tilgen, W, Pfohler, C.Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol. 2005;152(5): 931–8.CrossRefGoogle ScholarPubMed
5.Powell, SF, Dudek, AZ.Treatment of melanoma-associated retinopathy. Curr Treat Options Neurol. 2010;12(1):54–63.CrossRefGoogle ScholarPubMed
You have
Access
- 3
- Cited by